Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.17
-0.53 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
32.00
+0.83 (2.66%)
Pre-market: Nov 5, 2024, 5:35 AM EST
Immunocore Holdings Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Immunocore Holdings stock have an average target of 74.75, with a low estimate of 24 and a high estimate of 100. The average target predicts an increase of 139.81% from the current stock price of 31.17.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IMCR stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 3 |
| Buy | 8 | 8 | 7 | 7 | 7 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 14 | 14 | 13 | 12 | 12 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Sell Initiates $24 | Strong Sell | Initiates | $24 | -23.00% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +220.82% | Oct 24, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $80 → $74 | Buy | Maintains | $80 → $74 | +137.41% | Oct 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +220.82% | Sep 17, 2024 |
Financial Forecast
Revenue This Year
318.01M
from 249.43M
Increased by 27.50%
Revenue Next Year
351.90M
from 318.01M
Increased by 10.66%
EPS This Year
-1.57
from -1.13
EPS Next Year
-2.19
from -1.57
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 408.7M | 445.1M | 544.9M | ||
| Avg | 318.0M | 351.9M | 391.2M | ||
| Low | 291.8M | 301.4M | 315.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 63.9% | 40.0% | 54.8% | ||
| Avg | 27.5% | 10.7% | 11.2% | ||
| Low | 17.0% | -5.2% | -10.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.12 | -0.98 | -1.16 | ||
| Avg | -1.57 | -2.19 | -2.55 | ||
| Low | -2.16 | -3.38 | -3.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.